Mantha sanni ( Autism Spectrum Disorder) in Children

A Clinical Assessment And Evaluation Of Mantha Sanni (Autism Spectrum Disorder) with the Siddha Therapeutic Management in Children. - MS(ASD)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008698

Enrollment

Registered

2017-05-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Childern with Autism spectrum disorder

Interventions

Intervention1: Internal Medicine: vettiver(Vettivera zizanoides)- 1/4 palam Vizhamichi (Plectranthes vettiveroides ) - 1/4 palam Chukku (Zingiber officinalae ) - 1/4 palam Parpadagam( Hedyotis corym

Eligibility

Inclusion criteria

Inclusion criteria: • Children of age group under 3- 12 years • Clinically diagnosed as a ASD • Impaired social interaction • Mild aggressive • Repetitive behaviour • Lack of eye contact • Blabble sound

Exclusion criteria

Exclusion criteria: • H/o epilepsy • H/o severe aggressive with ADHD • H/o cerebral palsy • H/o congenital heart disease • Any other serious illness

Design outcomes

Primary

Measure	Time frame
A Clinical Assessment and Evaluation of ManthaSanni (Autism Spectrum Disorder) with Siddha Therapeutic Management in ChildrenTimepoint: 30 patients	—

Secondary

Measure	Time frame
To renovate the social impairment, eye contact and to slow down the behaviour wise emotional, repetitive hyperactive and blabble unwanted echoes .Timepoint: 30 patients	—

Countries

India

Contacts

Public ContactDrMMeenakshi sundaram

National institute of siddha

drarulmozhi@yahoo.co.in9500151930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026